Homeless With Cancer: An Unrecognized Problem in the United States

Autor: Barbara A. Biedrzycki

Publikováno v: Clinical journal of oncology nursing. 22(6)

Homelessness is a national problem that is worsening. Some challenges the homeless face-lack of shelter, food, health care, support, and opportunities-are well known. Cancer, an unrecognized problem among the homeless, is a leading cause of their dea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df29b9a1b9d5664426ce293379d5fa3e
https://pubmed.ncbi.nlm.nih.gov/30452000

Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation

Autor: Elizabeth M. Jaffee, Dung T. Le, James M. Burke, Elizabeth A. Sugar, Irena Tartakovsky, Kristen Hege, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Beth Onners, John Nemunaitis, Barbara A. Biedrzycki

Publikováno v: Clinical Cancer Research. 14:1455-1463

Purpose: The combination of chemotherapy and immunotherapy has not been examined in patients with advanced pancreatic cancer. We conducted a study of two granulocyte macrophage colony-stimulating factor–secreting pancreatic cancer cell lines (CG802

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530d5f7c0f05855c70adb64b83315781
https://doi.org/10.1158/1078-0432.ccr-07-0371

Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation

Autor: Elizabeth M. Jaffee, Drew M. Pardoll, Seamus O'Reilly, Barbara A. Biedrzycki, Charles J. Yeo, John L. Cameron, K G Schepers, Marti Goemann, Keith D. Lillemoe, Ross A. Abrams, Ralph H. Hruban, J. Coleman, Ross C. Donehower, Daniel A. Laheru, Patricia R. Sauter, Louise B. Grochow

Publikováno v: Journal of Clinical Oncology. 19:145-156

PURPOSE: Allogeneic granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting tumor vaccines can cure established tumors in the mouse, but their efficacy against human tumors is uncertain. We have developed a novel GM-CSF–secreting panc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ef082c03b211783542ae60a2b590f4b
https://doi.org/10.1200/jco.2001.19.1.145

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: A phase II trial of safety, efficacy, and immune activation

Autor: Eric R. Lutz, Dung T. Le, Ralph H. Hruban, Miri Choi, John L. Cameron, Keith D. Lillemoe, Elizabeth A. Sugar, Sara Solt, Elizabeth M. Jaffee, Joseph M. Herman, Steven Piantadosi, Beth Onners, Daniel A. Laheru, Rajni Sharma, Barry Kobrin, Barbara A. Biedrzycki, Peter B. Illei, Irena Tartakovsky, Ross A. Abrams, Charles J. Yeo

Publikováno v: Eric, L; Yeo, CJ; Lillemoe, KD; Biedrzycki, B; Kobrin, B; Herman, J; et al.(2011). A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: A phase II trial of safety, efficacy, and immune activation. Annals of Surgery, 253(2), 328-335. doi: 10.1097/SLA.0b013e3181fd271c. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0319j9n4
Annals of surgery, vol 253, iss 2

Purpose: Surgical resection provides the only possibility of cure for pancreas cancer. A standard adjuvant approach has not been established. We tested the safety and efficacy of a granulocyte-macrophage colony-stimulating factor (GM-CSF)-based immun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f56007e9b51d6f8905a025f6d012e872
http://www.escholarship.org/uc/item/0319j9n4

K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate

Autor: Yvette L. Kasamon, Guang Haun Tu, Elizabeth Garrett-Mayer, Christina Y. Chia, B. D. Smith, Hua Ling Tsai, Carole B. Miller, Lu Qin, Barbara A. Biedrzycki, Jeanne Kowalski, Kathleen M. Murphy, Richard Jones, Hyam I. Levitsky, Kristen Hege, Thomas Harding, Christopher D. Gocke

Purpose: Chronic myeloid leukemia (CML) can be responsive to T-cell–mediated immunity. K562/granulocyte macrophage-colony stimulating factor (GM-CSF) is a GM-CSF producing vaccine derived from a CML cell line that expresses several CML-associated a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36845e50673d477c4e6e9ef4f018be3
https://europepmc.org/articles/PMC2804932/